Actuate Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -21.4% | +21.4% | -39.3% | +528.7% | +110.5% | -5.6% | +40.4% | +14.0% | -14.4% | -12.0% | -1.2% | – | |
| – | +245.5% | +23.0% | +12.7% | -265.3% | – | +19.1% | -66.3% | -1,707.8% | – | – | – | – | |
| – | – | – | – | – | +66.7% | -100.0% | – | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -78.0% | +2,232.3% | -100.5% | +22.0% | – | +152.5% | -100.2% | -72.4% | – | – | |
| – | – | – | – | – | -137.1% | – | – | +300.7% | -136.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.